Martin Weisser

Martin Weisser

UNVERIFIED PROFILE

Are you Martin Weisser?   Register this Author

Register author
Martin Weisser

Martin Weisser

Publications by authors named "Martin Weisser"

Are you Martin Weisser?   Register this Author

27Publications

870Reads

48Profile Views

Mechanistic Investigations of Diarrhea Toxicity Induced by Anti-HER2/3 Combination Therapy.

Mol Cancer Ther 2018 07 13;17(7):1464-1474. Epub 2018 Apr 13.

Pharma Development Safety Science, Drug Licensing and Early Development, F. Hoffmann-La Roche Ltd, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-17-1268DOI Listing
July 2018

Clinical development of HER3-targeting monoclonal antibodies: Perils and progress.

Cancer Treat Rev 2018 Jul 18;68:111-123. Epub 2018 Jun 18.

Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2018.06.011DOI Listing
July 2018

Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy.

J Immunother Cancer 2017 07 18;5(1):53. Epub 2017 Jul 18.

Roche Pharmaceutical Research and Early Development, Roche Innovation Center Munich, Nonnenwald 2, Penzberg, 82377, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-017-0257-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514481PMC
July 2017

An optimized workflow for improved gene expression profiling for formalin-fixed, paraffin-embedded tumor samples.

J Clin Bioinforma 2013 May 3;3(1):10. Epub 2013 May 3.

Pharma Research and Early Development (pRED), Roche Diagnostics GmbH, TR-H, Bldg 231/206a, Nonnenwald 2, 82377 Penzberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/2043-9113-3-10DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660273PMC
May 2013

Advanced age and high initial WBC influence the outcome of inv(3) (q21q26)/t(3;3) (q21;q26) positive AML.

Leuk Lymphoma 2007 Nov;48(11):2145-51

Medical Department III, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190701632848DOI Listing
November 2007

Feasibility of using the combined MDS-EVI1/EVI1 gene expression as an alternative molecular marker in acute myeloid leukemia: a report of four cases.

Cancer Genet Cytogenet 2007 Aug;177(1):64-9

Medical Department III, Klinikum Grosshadern, Ludwig-Maximilians-University, Marchioninistrasse 15, 81377 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cancergencyto.2007.05.003DOI Listing
August 2007

Long-term follow-up of allogeneic HSCT for CML reveals significant improvement in the outcome over the last decade.

Ann Hematol 2007 Feb 9;86(2):127-32. Epub 2006 Nov 9.

Clinical Cooperative Group for Haematopoetic Cell Transplantation, Department of Medicine III, University of Munich, Klinikum Grosshadern and GSF-National Research Center for Environment and Health, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-006-0196-zDOI Listing
February 2007

Acute myeloid leukemia (AML) with t(8;21)(q22;q22) relapsing as AML with t(3;21)(q26;q22).

Cancer Genet Cytogenet 2006 Jul;168(2):172-4

Department of Clinical Chemistry, Ludwig-Maximilians University of Munich, Marchioninistrasse 15, 81377 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cancergencyto.2006.02.011DOI Listing
July 2006

A comparison of donor lymphocyte infusions or imatinib mesylate for patients with chronic myelogenous leukemia who have relapsed after allogeneic stem cell transplantation.

Haematologica 2006 May 19;91(5):663-6. Epub 2006 Apr 19.

Department of Internal Medicine III, University of Munich, Klinikum Grosshadern, Munich, Germany.

View Article

Download full-text PDF

Source
May 2006

Risk assessment by monitoring expression levels of partial tandem duplications in the MLL gene in acute myeloid leukemia during therapy.

Haematologica 2005 Jul;90(7):881-9

Laboratory for Leukemia Diagnostics, Medical Department III, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany.

View Article

Download full-text PDF

Source
July 2005

New score predicting for prognosis in PML-RARA+, AML1-ETO+, or CBFBMYH11+ acute myeloid leukemia based on quantification of fusion transcripts.

Blood 2003 Oct 3;102(8):2746-55. Epub 2003 Jul 3.

Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, University Hospital Grosshadern, Ludwig-Maximilians-University, Marchioninistrasse 15, 81377 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2003-03-0880DOI Listing
October 2003